Mark Christianson is Business Development Director of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 230,732 shares of NMTC, which is worth approximately $159,205. The most recent transaction as insider was on Jun 23, 2021, when has been sold 11,300 shares (Common Stock) at a price of $6.74 per share, resulting in proceeds of $76,162. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 231K
0.11% 3M change
21.43% 12M change
Total Value Held $159,205

Mark Christianson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2021
SELL
Open market or private sale
$76,162 $6.74 p/Share
11,300 Reduced 1.04%
1,077,906 Common Stock
MC

Mark Christianson

Business Development Director
Eden Prairie, MN

Track Institutional and Insider Activities on NMTC

Follow NEUROONE MEDICAL TECHNOLOGIES Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC